Free tool
Diagnostics stocks
We cover 122 companies grouped under the Diagnostics theme. The median market value in the group is $78.37M. Across the group, the median move over the past trading day is 0.00%. 39% of the 120 with a 200-day average trade above it. Price change over the past year runs from −80.6% to +78.3% across the middle 80 percent of the group, with a median of −15.1%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
122 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| 6869.T | Sysmex Corporation | $7.42B | Mid cap | +5.65% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| SHL.AX | Sonic Healthcare Limited | $7.20B | Mid cap | −11.60% |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +107.18% |
| GRAL | GRAIL, Inc. | $3.69B | Mid cap | +150.69% |
| VCYT | Veracyte, Inc. Common Stock | $3.54B | Mid cap | +49.04% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
| PSNL | Personalis, Inc. | $1.84B | Small cap | +267.02% |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.53% |
| 4544.T | H.U. Group Holdings, Inc. | $1.26B | Small cap | +11.45% |
| OPK | OPKO Health, Inc. | $1.11B | Small cap | +7.19% |
| QDEL | QuidelOrtho Corporation | $1.03B | Small cap | −45.57% |
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| 4694.T | BML, Inc. | $862.01M | Small cap | +7.64% |
| IDX.AX | Integral Diagnostics Limited | $638.89M | Small cap | −17.78% |
| DASA3.SA | Diagnósticos da América S.A. | $636.08M | Small cap | +111.29% |
| FLGT | Fulgent Genetics, Inc. | $548.93M | Small cap | −7.34% |
| 137310.KS | SD Biosensor, Inc. | $536.97M | Small cap | −36.08% |
| 4549.T | Eiken Chemical Co., Ltd. | $486.14M | Small cap | −2.85% |
| CEVI.ST | CellaVision AB (publ) | $413.78M | Small cap | −3.32% |
| ACL.AX | Australian Clinical Labs Limited | $386.24M | Small cap | +12.06% |
| VOX.WA | Voxel S.A. | $382.56M | Small cap | −20.15% |
| NIOX.L | NIOX Group Plc | $382.51M | Small cap | −6.05% |
| N3B.F | Anbio Biotechnology | $356.84M | Small cap | −86.59% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −84.06% |
| 197A.T | TAUNS LABORATORIES INC. | $337.20M | Small cap | −11.01% |
| YDES | YD Bio Ltd | $331.49M | Small cap | −64.97% |
| SBS.DE | Stratec SE | $324.34M | Small cap | −16.29% |
| IDHC.L | Integrated Diagnostics Holdings plc | $317.40M | Small cap | +20.85% |
| BDSX | Biodesix, Inc. | $296.22M | Small cap | +186.48% |
| MYGN | Myriad Genetics, Inc. | $291.73M | Small cap | −45.84% |
| OSUR | OraSure Technologies, Inc. | $260.70M | Small cap | +20.38% |
| ALERS.PA | Eurobio Scientific Société anonyme | $232.78M | Small cap | −18.97% |
| HLS.AX | Healius Limited | $224.62M | Small cap | −55.00% |
| 4595.T | Mizuho Medy Co.,Ltd. | $207.18M | Small cap | +13.41% |
| LUCD | Lucid Diagnostics Inc. | $190.95M | Small cap | −12.93% |
| XGN | Exagen Inc. | $184.11M | Small cap | −22.84% |
| PEB.AX | Pacific Edge Limited | $182.42M | Small cap | +64.00% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | $179.10M | Small cap | +21.25% |
| S2B.WA | Syn2bio S.A. | $149.26M | Small cap | +81.79% |
| IMDX | Insight Molecular Diagnostics Inc. | $145.30M | Small cap | +78.31% |
| EKF.L | EKF Diagnostics Holdings plc | $144.58M | Small cap | −13.90% |
| BVXP.L | Bioventix PLC | $124.78M | Small cap | −30.64% |
| SCP.WA | Scope Fluidics S.A. | $120.56M | Small cap | −9.34% |
| S84.F | Scope Fluidics S.A. | $119.81M | Small cap | −9.76% |
| QUCY | Quantum Cyber N.V. | $110.13M | Small cap | −20.93% |
| BNR | Burning Rock Biotech Limited | $108.84M | Small cap | +13.95% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $106.02M | Small cap | −60.27% |
| BIOPOR.CO | BioPorto A/S | $95.88M | Micro cap | −6.25% |
| BB1.AX | BLINKLAB FPO [BB1] | $93.89M | Micro cap | +67.65% |
| 7V0.DE | Novogenia AG | $89.68M | Micro cap | −29.07% |
| 6678.T | Techno Medica Co., Ltd. | $88.56M | Micro cap | +10.19% |
| AALR3.SA | Alliança Saúde e Participações S.A. | $87.29M | Micro cap | −52.27% |
| SERA | Sera Prognostics, Inc. | $86.00M | Micro cap | −17.42% |
| MDXH | MDxHealth SA | $70.73M | Micro cap | −83.84% |
| LDX.AX | Lumos Diagnostics Holdings Limited | $67.70M | Micro cap | −19.23% |
| DXR | Daxor Corporation | $58.38M | Micro cap | −7.83% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| ALKLH.PA | KLEA HOLDING | $54.68M | Micro cap | −29.55% |
| CYC.AX | Cyclopharm Limited | $46.85M | Micro cap | −47.50% |
| BIOBV.HE | Biohit Oyj | $46.16M | Micro cap | −8.24% |
| ABLD.PA | ABL Diagnostics Société anonyme | $45.06M | Micro cap | −47.32% |
| ALNOV.PA | Novacyt S.A. | $43.09M | Micro cap | +8.44% |
| NCYT.L | Novacyt S.A. | $43.04M | Micro cap | +9.18% |
| PAVM | PAVmed Inc. | $40.78M | Micro cap | −64.04% |
| ABDX.L | Abingdon Health Plc | $37.08M | Micro cap | +100.00% |
| 2385.T | Soiken Holdings Inc. | $36.98M | Micro cap | +16.58% |
| NXN.AX | Nexsen Ltd | $34.40M | Micro cap | −17.86% |
| COV.AX | Cleo Diagnostics Ltd | $33.34M | Micro cap | −5.56% |
| ACARIX.ST | Acarix AB (publ) | $31.56M | Micro cap | −15.27% |
| MBX.TO | Microbix Biosystems Inc. | $30.67M | Micro cap | +25.00% |
| GDR.L | genedrive plc | $28.48M | Micro cap | +78.06% |
| NN6.DE | NanoRepro AG | $27.17M | Micro cap | −6.09% |
| MAP.AX | Microba Life Sciences Limited | $27.10M | Micro cap | −42.11% |
| ALIKO.PA | Ikonisys S.A. | $26.24M | Micro cap | −3.95% |
| RENX.L | Renalytix Plc | $25.64M | Micro cap | −27.35% |
| RHY.AX | Rhythm Biosciences Limited | $24.60M | Micro cap | −3.00% |
| 6090.T | Human Metabolome Technologies, Inc. | $21.69M | Micro cap | −14.95% |
| PIQ.AX | Proteomics International Laboratories Ltd | $19.54M | Micro cap | −48.44% |
| ALBIO.PA | Biosynex SA | $19.41M | Micro cap | −22.70% |
| CLBX.L | CelLBxHealth plc | $19.39M | Micro cap | −80.77% |
| URT.WA | Urteste S.A. | $18.10M | Micro cap | −14.03% |
| BDX.AX | BCAL Diagnostics Limited | $17.70M | Micro cap | −17.46% |
| IIQ.AX | INOVIQ Ltd | $17.65M | Micro cap | −56.25% |
| GMT.WA | Genomtec S.A. | $17.04M | Micro cap | −38.02% |
| ADVB | Advanced Biomed Inc. | $15.17M | Micro cap | −4.38% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.90M | Micro cap | −33.59% |
| GSS.AX | Genetic Signatures Limited | $13.51M | Micro cap | −72.33% |
| TRI.AX | TrivarX Limited | $13.23M | Micro cap | +77.78% |
| BOUL.ST | Boule Diagnostics AB (publ) | $13.10M | Micro cap | −46.85% |
| BMX.WA | BioMaxima S.A. | $11.54M | Micro cap | −22.30% |
| AT1.AX | Atomo Diagnostics Limited | $10.99M | Micro cap | −15.00% |
| GENI.L | GENinCode Plc | $9.25M | Micro cap | −37.50% |
| CIZ.L | Cizzle Biotechnology Holdings Plc | $8.70M | Micro cap | +7.14% |
| ACE.ST | Ascelia Pharma AB (publ) | $8.59M | Micro cap | −87.29% |
| CODX | Co-Diagnostics, Inc. | $7.63M | Micro cap | −87.07% |
| ACON | Aclarion, Inc. | $7.18M | Micro cap | −65.89% |
| OBD.L | Oxford BioDynamics Plc | $7.17M | Micro cap | −72.63% |
| INBS | Intelligent Bio Solutions Inc. | $7.12M | Micro cap | −83.95% |
| VRCI.L | Verici Dx plc | $7.02M | Micro cap | −57.14% |
| NDRA | ENDRA Life Sciences Inc. | $6.84M | Micro cap | +6.74% |
| AIDX | 20/20 Biolabs, Inc. | $6.75M | Micro cap | −97.79% |
| CNSL.L | Cambridge Nutritional Sciences plc | $6.17M | Micro cap | −41.54% |
| IBX.AX | Imagion Biosystems Limited | $5.74M | Micro cap | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.65M | Micro cap | −45.58% |
| BMRA | Biomerica, Inc. | $5.47M | Micro cap | −48.40% |
| VNRX | VolitionRx Limited | $5.25M | Micro cap | −97.21% |
| ALPRE.PA | Predilife S.A. | $5.11M | Micro cap | −65.85% |
| REVB | Revelation Biosciences, Inc. | $3.98M | Micro cap | −91.21% |
| BIAF | bioAffinity Technologies, Inc. | $3.14M | Micro cap | −30.52% |
| ADTX | Aditxt, Inc. | $2.59M | Micro cap | −100.00% |
| ONCO | Onconetix, Inc. | $2.54M | Micro cap | −99.57% |
| VRAX | Virax Biolabs Group Limited | $2.32M | Micro cap | +275.97% |
| 2CUREX.ST | 2cureX AB (publ) | $1.75M | Micro cap | −79.23% |
| BJDX | Bluejay Diagnostics, Inc. | $948.00K | Micro cap | −83.87% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.